...
首页> 外文期刊>Hepato-gastroenterology. >Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
【24h】

Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.

机译:根治性切除大肠癌后的复发模式至少持续了十年。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: To investigate the recurrence patterns and interval from initial surgery in patients with curatively resected colorectal cancer followed for a minimum of 10 years. METHODOLOGY: We retrospectively reviewed 418 patients who had undergone curative resection for colon cancer (n = 246) or rectal cancer (n = 169). Follow-up periods ranged from 10 to 23 years. Main outcome measures were interval until recurrence, site of first recurrence, and influence of adjuvant chemotherapy. RESULTS: 26 (6%) had been lost to follow-up by 10 years and 143 (34%) had died. The most common site of recurrence was liver in colon cancer and locoregional in rectal cancer. The cumulative recurrence rate in colon cancer was 100% at 4 years. In rectal cancer, it was 89% at 5 years, 98% at 7 years and 100% at 10 years. The interval until recurrence was longer in rectal cancer (26.0 +/- 24.2 months) than in colon cancer (17.1 +/- 11.0 months) (p = 0.03). It was also longer in patients receiving than in those not receiving adjuvant chemotherapy (p < 0.01). The interval until lung metastasis was longer than that until liver metastasis in colon cancer (p = 0.04), and longer than that until locoregional recurrence in rectal cancer (p = 0.03). The interval until recurrence in the colon cancer was shorter for stage III than for stage II (p = 0.02). CONCLUSIONS: Surveillance for recurrences, particularly for relapses in the liver and lung, should be performed for at least 4 years in colon cancer patients. Patients with rectal cancer should be followed for a longer period than those with colon cancer, focusing on locoregional, liver and lung recurrence. It is particularly noteworthy that adjuvant chemotherapy may prolong the interval until recurrence and the interval until lung metastasis is relatively longer.
机译:背景/目的:研究治愈性结直肠癌患者至少10年的复发模式和首次手术间隔。方法:我们回顾性分析了418例因结肠癌(n = 246)或直肠癌(n = 169)进行过根治性切除的患者。随访期为10至23年。主要结局指标为复发间隔时间,首次复发部位以及辅助化疗的影响。结果:随访10年,丢失26例(6%),死亡143例(34%)。复发的最常见部位是结肠癌中的肝脏和直肠癌中的局部性。结肠癌的累积复发率在4年时为100%。在直肠癌中,5年时为89%,7年时为98%,10年时为100%。直肠癌的复发间隔(26.0 +/- 24.2个月)比结肠癌的复发间隔(17.1 +/- 11.0个月)更长(p = 0.03)。与未接受辅助化疗的患者相比,接受治疗的患者更长(p <0.01)。在结肠癌中直到肺转移的间隔要比直到肝转移的间隔长(p = 0.04),而在直肠癌中要比直到局部复发的间隔长(p = 0.03)。 III期结肠癌直到复发的间隔比II期短(p = 0.02)。结论:对于结肠癌患者,应进行至少4年的复发特别是肝和肺复发的监测。直肠癌患者应比结肠癌患者接受更长时间的随访,重点是局部,肝和肺的复发。尤其值得注意的是,辅助化疗可能会延长复发间隔和直到肺转移的间隔相对较长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号